19 December 2017 - Deborah Wilkes
Archived
Procter & Gamble has appointed Joseph Jimenez, chief executive officer of Novartis, to its board of directors with effect from 1 March 2018. Nelson Peltz of activist investor Trian Fund Management will also join the board.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.